Open AccessProlonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: A case series
Author(s) -
Jessica M. Downes,
Jennifer A. Foster
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_2271_20
Subject(s) - medicine , covid-19 , type 2 diabetes , diabetes mellitus , insulin , infection control , intensive care medicine , virology , endocrinology , disease , outbreak , infectious disease (medical specialty)
Three independent cases of adult patients are described who had relative control of their type 2 diabetes prior to infection with COVID-19. Each of the described patients had different levels of severity of COVID-19 but all experienced significant and prolonged hyperglycemia for at least 1-2 months after resolution of their COVID-19 infection. Two of the three patients required intensifying insulin regimens for two months after COVID-19 infection. The case study helps to inform primary care providers about the possible need for the intensification of antihyperglycemic medications for several weeks to months after the resolution of COVID-19 infection to minimize prolonged hyperglycemia.